Stocks shake off an early slump and head higher
Banks led financial stocks higher.
Medical equipment makers helped health care stocks reverse course after an early loss. Danaher rose 2.4% after reporting solid second quarter financial results.
Market indexes were down most of the day after
Consumer-oriented and energy stocks also fell.
Corporate earnings are in full swing and investors have been cautiously assessing results and company statements. Only about 13% of S&P 500 companies have reported, according to FactSet, and analysts expect profits to fall 2.4% overall.
Several other large companies are expected to report results later Thursday, including
The latest round of corporate earnings comes ahead of a highly anticipated
KEEPING SCORE: The S&P 500 index rose 0.4% as of
ANALYST'S TAKE: Investors have so far spent the week pulling back as corporate earnings results give them a better picture of the economy. The market has spent much of the year gaining ground, but remains volatile amid economic policy concerns and a lingering trade disputes.
"We've been watching the game and now we actually get to see the scorecard," said
The results so far have reflected financial strength from banks as the broader economy holds up with solid job growth and consumer confidence.
"The consumers are still making things happen out there and it's showing up in the earnings to a surprising degree," he said.
THE BIGGER PICTURE: The market is still on track for a weekly loss despite the S&P 500 hitting a record high close on Monday. Stocks have been volatile throughout the week and have been mostly lower since Tuesday.
The decline so far this week has barely dented yearly gains. The S&P 500 is still up 19% for the year, while the Nasdaq is still holding on to 23% in gains. The Dow is up 16% for the year.
CHUGGING ALONG:
SHRINKING STREAM:
LIGHTING UP: Philip Morris rose 8.9% after the cigarette maker raised its profit forecast for the year following a solid second quarter. The maker of
MISSING PARTS:



CTD Holdings Scientific Advisory Board Endorses Alzheimer’s Disease as Next Indication for Company’s Trappsol® Cyclo™ Drug Development Program
Best’s Commentary: Change in UK Ogden Discount Rate Falls Short of Industry Expectations
Advisor News
- How smart investments prepare clients for inflation
- Amid slew of corporate tax ideas, Newsom chose one likely to hit people’s premiums
- The biggest risk to your clients’ financial plans isn’t market volatility
- Initiative looks at how caregiving impacts workplace benefits
- Will rising retirement needs spark an annuity boom?
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- Fortitude Re Completes $500 Million FABN Issuance
- Reframing retirement income for greater certainty
- Jackson Introduces Dow Jones Industrial Average Index Option, Flexible Premiums, Six-Year Rate Guarantee in Latest Registered Index-Linked Annuity Launch
- Senior Market Sales® Fortifies Annuity Reach With Acquisition of Retirement Planning Firm Stratton & Company
More Annuity NewsHealth/Employee Benefits News
- Final rules for Medicaid work requirements are out. Here's what you need to know.
- Hyde-Smith blasts health care delays
- WNY health insurers seek rate hikes of 9% to 24% for 2027
- Healthcare now costs more than mortgages
- Fairview won’t accept seniors with UnitedHealth Medicare Advantage plans next year
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Issue Credit Ratings of Weston2038 LLC’s Credit-Linked Notes
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- Greg Lindberg moves to halt $1.65B restitution order, claims he ‘overpaid’
- Fidelity Investments® to Expand Target Date Lineup With Launch of Guaranteed Income Solution
- KBRA Releases Research – Private Credit: Much Ado About Nothing – Perspectives on Columbia Business School Paper About Private Ratings
More Life Insurance News